StockWatch
·
Pharmaceuticals
Board Meeting31 Jul 2026, 12:23 pm

Zim Laboratories Board Meeting on Aug 6 to Approve Unaudited Financial Results

AI Summary

Zim Laboratories Ltd has announced that its Board of Directors will convene on August 6, 2026. The primary agenda for this meeting is to consider and approve the company's Unaudited Financial Results for the quarter ending June 30, 2026. These results will be presented on both a standalone and consolidated basis. Additionally, the company has informed about the closure of the trading window for its securities, effective from July 1, 2026, until August 8, 2026, in compliance with SEBI regulations regarding insider trading.

Key Highlights

  • Board meeting scheduled for August 6, 2026.
  • To approve Unaudited Financial Results for Q1 FY27.
  • Results will be standalone and consolidated.
  • Trading window closed from July 1 to August 8, 2026.